HC Wainwright Has Pessimistic Outlook of ATNM Q2 Earnings
Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Free Report) – Research analysts at HC Wainwright cut their Q2 2025 earnings estimates for shares of Actinium Pharmaceuticals in a note issued to investors on Monday, May 12th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings of ($0.32) per share for the quarter, down […]
Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Free Report) – Research analysts at HC Wainwright cut their Q2 2025 earnings estimates for shares of Actinium Pharmaceuticals in a note issued to investors on Monday, May 12th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings of ($0.32) per share for the quarter, down […]
